Skip to content

Book value per share at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
-$1.12+51.0%
LQD
Liquidia CorporationLQDA
$1.07+84.0%
United Therapeutics logo
United TherapeuticsUTHR
$125.02-10.7%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Calculated from Trevi Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s book value per share?
Trevi Therapeutics, Inc. (TRVI) reported book value per share of $1.18 in Q1 2026.
How has Trevi Therapeutics, Inc.'s book value per share changed year-over-year?
Trevi Therapeutics, Inc.'s book value per share increased by 39.8% year-over-year, from $0.85 to $1.18.
What is the long-term trend for Trevi Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s book value per share has grown at a -2.1% compound annual growth rate (CAGR), from $1.51 to $1.36.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.